Takeda Pharmaceutical Co. Ltd. - Capital Expenditures

Takeda Pharmaceutical Co. Ltd.'s Fiscal Year is From April To March - All Figures are in JPY, Billions.

The item "Capital-Expenditures" stands at 194.62 Billion Japanese Yens for the trailing twelve months (TTM) period ending 09/30/2025.

Takeda Pharmaceutical Co. Ltd.'s second quarter result of 52.82 Billion JPY for the item "Capital Expenditures" represents an increase of 10.25 percent compared to it's first quarter result.

Also, Takeda Pharmaceutical Co. Ltd.'s second quarter result of 52.82 Billion JPY for the item "Capital Expenditures" represents an increase of 6.78 percent compared to it's second quarter result of last year.

Looking again at the trailing twelve months series (TTM), Takeda Pharmaceutical Co. Ltd.'s second quarter result of 194.62 Billion JPY for the item "Capital Expenditures" represents an increase of 1.75 percent compared to it's first quarter result.


Regarding the One-Year-Change of the series, the current value constitutes a decrease of -1.97 percent compared to the value the year prior.
The 1 year change in percent is -1.97.
The 3 year change in percent is 45.16.
The 5 year change in percent is 58.90.
The 10 year change in percent is 118.95.

The Serie's long term average value is 162.25 Billion Japanese Yens. It's latest available value, on 09/30/2025, is 19.95 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 12/31/2011, to it's latest available value, on 09/30/2025, is +415.67%.
The Serie's change in percent from it's maximum value, on 09/30/2023, to it's latest available value, on 09/30/2025, is -76.66%.